Australia's most trusted
source of pharma news
Tuesday, 26 November 2024
Posted 22 November 2024 AM
Omico Founder, Professor David Thomas, has been awarded the prestigious NSW Premier's Awards for Outstanding Cancer Research, recognising his profound contributions to advancing cancer research and patient outcomes.
The accolade recognises a career focused on sarcoma research, genomics and the pioneering integration of precision oncology as routine care across New South Wales and Australia.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.